跳至主要内容
临床试验/NCT00787995
NCT00787995终止不适用

A Multicenter, Multinational, Longitudinal Clinical Assessment Study of Subjects With Mucopolysaccharidosis IVA (Morquio Syndrome)

BioMarin Pharmaceutical0 个研究点目标入组 353 人开始时间: 2008年10月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
353
主要终点
Respiratory Function

研究概览

简要总结

This multicenter, multinational, longitudinal study will quantify endurance and respiratory function in subjects diagnosed with MPS IVA and will better characterize the spectrum of symptoms and biochemical abnormalities in MPS IVA disease over time.

研究设计

研究类型
Observational
观察模型
Case Only

入排标准

性别
All
接受健康志愿者

入选标准

  • Willing and able to provide written, signed informed consent, or in the case of subjects age < 18 years, provide written assent (if required) and written informed consent by a legally authorized representative after the nature of the study has been explained, and prior to any research-related procedures.
  • Documented history of reduced GALNS activity relative to the normal range of the laboratory performing the assay, or documented result of molecular genetic testing confirming diagnosis of MPS IVA.
  • Willing and able to comply with all study procedures.

排除标准

  • Use of any investigational product or investigational medical device within 30 days prior to screening.
  • Previous hematopoietic stem cell transplant (HSCT).
  • Concurrent disease or condition that would interfere with study participation or pose a safety concern.

结局指标

主要结局

Respiratory Function

时间窗: Study Visit

Endurance

时间窗: Study Visit

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验

A Clinical Assessment Study of Subjects With... | 临床试验